Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study

Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybjærg-Hansen A.

BMJ. 2017 Apr 24;357:j1648. doi: 10.1136/bmj.j1648.

Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, Sobarzo-Sanchez E, Nabavi SF.

CNS Neurol Disord Drug Targets. 2017;16(4):387-397. doi: 10.2174/1871527316666170328113309.

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Chiti F, Dobson CM.

Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115. Epub 2017 May 12.

Loss of gait control assessed by cognitive-motor dual-tasks: pros and cons in detecting people at risk of developing Alzheimer's and Parkinson's diseases

Belghali M, Chastan N, Cignetti F, Davenne D, Decker LM.

Geroscience. 2017 Jun;39(3):305-329. doi: 10.1007/s11357-017-9977-7. Epub 2017 May 27.

The impact of obesity on neurodegenerative diseases

Mazon JN, de Mello AH, Ferreira GK, Rezin GT.

Life Sci. 2017 Aug 1;182:22-28. doi: 10.1016/j.lfs.2017.06.002. Epub 2017 Jun 3.

Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM.

Pharm Res. 2017 Dec;34(12):2614-2627. doi: 10.1007/s11095-017-2199-y. Epub 2017 Jun 6.

Gene networks in neurodegenerative disorders

Recabarren D, Alarcón M.

Life Sci. 2017 Aug 15;183:83-97. doi: 10.1016/j.lfs.2017.06.009. Epub 2017 Jun 13.

Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease

Li Y, Zhao J, Hölscher C.

CNS Drugs. 2017 Aug;31(8):639-652. doi: 10.1007/s40263-017-0451-y.

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

Radad K, Moldzio R, Al-Shraim M, Kranner B, Krewenka C, Rausch WD.

CNS Neurol Disord Drug Targets. 2017;16(7):740-748. doi: 10.2174/1871527316666170623094728.

Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs

Lazarevic-Pasti T, Leskovac A, Momic T, Petrovic S, Vasic V.

Curr Med Chem. 2017;24(30):3283-3309. doi: 10.2174/0929867324666170705123509.

Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease

Itoh Y, Voskuhl RR.

PLoS One. 2017 Jul 17;12(7):e0181349. doi: 10.1371/journal.pone.0181349. eCollection 2017.

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L.

Alzheimers Res Ther. 2017 Jul 28;9(1):52. doi: 10.1186/s13195-017-0276-4.

Dietary Modulation of Oxidative Stress in Alzheimer's Disease

Thapa A, Carroll NJ.

Int J Mol Sci. 2017 Jul 21;18(7):1583. doi: 10.3390/ijms18071583.

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Alam Q, Alam MZ, Sait KHW, Anfinan N, Noorwali AW, Kamal MA, Khan MSA, Haque A.

Curr Drug Metab. 2017;18(9):868-876. doi: 10.2174/1389200218666170728115606.

The role of Th17 cells in auto-inflammatory neurological disorders

Tahmasebinia F, Pourgholaminejad A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):408-416. doi: 10.1016/j.pnpbp.2017.07.023. Epub 2017 Jul 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias